• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于抗2019冠状病毒病的潜在小干扰RNA的计算机预测与设计

In Silico Prediction and Designing of Potential siRNAs to be used as Antivirals Against SARS-CoV-2.

作者信息

Sohrab Sayed S, El-Kafrawy Sherif A, Abbas Aymn T, Bajrai Leena H, Azhar Esam I

机构信息

Special Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.

出版信息

Curr Pharm Des. 2021;27(32):3490-3500. doi: 10.2174/1381612827999210111194101.

DOI:10.2174/1381612827999210111194101
PMID:33430748
Abstract

BACKGROUND

The unusual pneumonia outbreak that originated in the city of Wuhan, China in December 2019 was found to be caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), or COVID-19.

METHODS

In this work, we have performed an in silico design and prediction of potential siRNAs based on genetic diversity and recombination patterns, targeting various genes of SARS-CoV-2 for antiviral therapeutics. We performed extensive sequence analysis to analyze the genetic diversity and phylogenetic relationships, and to identify the possible source of virus reservoirs and recombination patterns, and the evolution of the virus as well as we designed the siRNAs which can be used as antivirals against SARS-CoV-2.

RESULTS

The sequence analysis and phylogenetic relationships indicated high sequence identity and closed clusters with many types of coronavirus. In our analysis, the full-genome of SARS-CoV-2 showed the highest sequence (nucleotide) identity with SARS-bat-ZC45 (87.7%). The overall sequence identity ranged from 74.3% to 87.7% with selected SARS viruses. The recombination analysis indicated the bat SARS virus is a potential recombinant and serves as a major and minor parent. We have predicted 442 siRNAs and finally selected only 19 functional, and potential siRNAs.

CONCLUSION

The siRNAs were predicted and selected based on their greater potency and specificity. The predicted siRNAs need to be validated experimentally for their effective binding and antiviral activity.

摘要

背景

2019年12月起源于中国武汉市的不明原因肺炎疫情被发现是由严重急性呼吸综合征冠状病毒2(SARS-CoV-2),即新冠病毒引起的。

方法

在这项研究中,我们基于遗传多样性和重组模式,对潜在的小干扰RNA(siRNA)进行了计算机辅助设计和预测,靶向新冠病毒的各种基因用于抗病毒治疗。我们进行了广泛的序列分析,以分析遗传多样性和系统发育关系,确定病毒储存库的可能来源、重组模式以及病毒的进化,同时设计了可作为抗新冠病毒药物的siRNA。

结果

序列分析和系统发育关系表明,新冠病毒与多种冠状病毒具有高度的序列同一性和紧密的聚类。在我们的分析中,新冠病毒的全基因组与蝙蝠SARS-CoV-ZC45的序列(核苷酸)同一性最高(87.7%)。与选定的SARS病毒的总体序列同一性范围为74.3%至87.7%。重组分析表明,蝙蝠SARS病毒是一种潜在的重组病毒,可作为主要和次要亲本。我们预测了442个siRNA,最终仅筛选出19个具有功能且有潜力的siRNA。

结论

基于其更高的效力和特异性对siRNA进行了预测和筛选。预测的siRNA需要通过实验验证其有效结合和抗病毒活性。

相似文献

1
In Silico Prediction and Designing of Potential siRNAs to be used as Antivirals Against SARS-CoV-2.用于抗2019冠状病毒病的潜在小干扰RNA的计算机预测与设计
Curr Pharm Des. 2021;27(32):3490-3500. doi: 10.2174/1381612827999210111194101.
2
In silico prediction and experimental evaluation of potential siRNAs against SARS-CoV-2 inhibition in Vero E6 cells.针对Vero E6细胞中抑制严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的潜在小干扰RNA(siRNA)的计算机预测及实验评估
J King Saud Univ Sci. 2022 Jun;34(4):102049. doi: 10.1016/j.jksus.2022.102049. Epub 2022 Apr 26.
3
Genomic characterization and phylogenetic evolution of the SARS-CoV-2.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的基因组特征与系统发育进化
Acta Virol. 2020;64(4):496-500. doi: 10.4149/av_2020_403.
4
Effect of insilico predicted and designed potential siRNAs on inhibition of SARS-CoV-2 in HEK-293 cells.计算机预测和设计的潜在小干扰RNA对人胚肾293细胞中新型冠状病毒抑制作用的影响
J King Saud Univ Sci. 2022 Jun;34(4):101965. doi: 10.1016/j.jksus.2022.101965. Epub 2022 Mar 16.
5
Current understanding of an Emerging Coronavirus using in silico approach: Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2).使用计算机模拟方法了解新兴冠状病毒:严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)。
Braz J Biol. 2021 Sep 3;83:e247237. doi: 10.1590/1519-6984.247237. eCollection 2021.
6
Evitar: designing anti-viral RNA therapies against future RNA viruses.避免:针对未来的 RNA 病毒设计抗病毒 RNA 疗法。
Bioinformatics. 2022 Apr 28;38(9):2437-2443. doi: 10.1093/bioinformatics/btac144.
7
The Emergence of Human Pathogenic Coronaviruses: Lectins as Antivirals for SARS-CoV-2.人致病性冠状病毒的出现:作为针对 SARS-CoV-2 的抗病毒药物的凝集素。
Curr Pharm Des. 2020;26(41):5286-5292. doi: 10.2174/1381612826666200821120409.
8
Recognition of plausible therapeutic agents to combat COVID-19: An omics data based combined approach.识别有潜力对抗 COVID-19 的治疗药物:基于组学数据的综合方法。
Gene. 2021 Mar 1;771:145368. doi: 10.1016/j.gene.2020.145368. Epub 2020 Dec 17.
9
Prediction of putative potential siRNAs for inhibiting SARS-CoV-2 strains, including variants of concern and interest.预测针对 SARS-CoV-2 株(包括关注和感兴趣的变体)的潜在有效 siRNA。
Future Microbiol. 2022 Apr;17:449-463. doi: 10.2217/fmb-2021-0130. Epub 2022 Mar 14.
10
Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CL targeting repurposed drug candidates.SARS-CoV2 的地理多样性演变和针对复制酶 3CL 的计算机分析,以寻找可再利用药物的候选物。
J Transl Med. 2020 Jul 9;18(1):278. doi: 10.1186/s12967-020-02448-z.

引用本文的文献

1
Delivery of siRNAs against MERS-CoV in Vero and HEK-293 cells: A comparative evaluation of transfection reagents.在Vero细胞和HEK - 293细胞中递送针对中东呼吸综合征冠状病毒(MERS-CoV)的小干扰RNA(siRNAs):转染试剂的比较评估
J King Saud Univ Sci. 2023 Apr;35(3):102540. doi: 10.1016/j.jksus.2023.102540. Epub 2023 Jan 5.
2
Computational Design and Experimental Evaluation of MERS-CoV siRNAs in Selected Cell Lines.中东呼吸综合征冠状病毒(MERS-CoV)小分子干扰RNA(siRNAs)在选定细胞系中的计算设计与实验评估
Diagnostics (Basel). 2023 Jan 2;13(1):151. doi: 10.3390/diagnostics13010151.
3
In silico prediction and experimental evaluation of potential siRNAs against SARS-CoV-2 inhibition in Vero E6 cells.
针对Vero E6细胞中抑制严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的潜在小干扰RNA(siRNA)的计算机预测及实验评估
J King Saud Univ Sci. 2022 Jun;34(4):102049. doi: 10.1016/j.jksus.2022.102049. Epub 2022 Apr 26.
4
Effect of insilico predicted and designed potential siRNAs on inhibition of SARS-CoV-2 in HEK-293 cells.计算机预测和设计的潜在小干扰RNA对人胚肾293细胞中新型冠状病毒抑制作用的影响
J King Saud Univ Sci. 2022 Jun;34(4):101965. doi: 10.1016/j.jksus.2022.101965. Epub 2022 Mar 16.
5
Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract.用于呼吸道 COVID-19 疾病的 RNAi 治疗的纳米颗粒递送平台。
Int J Mol Sci. 2022 Feb 22;23(5):2408. doi: 10.3390/ijms23052408.
6
In Vitro Inhibitory Analysis of Rationally Designed siRNAs against MERS-CoV Replication in Huh7 Cells.针对 MERS-CoV 复制的理性设计 siRNAs 在 Huh7 细胞中的体外抑制分析。
Molecules. 2021 Apr 29;26(9):2610. doi: 10.3390/molecules26092610.